Association Between LRG and Histologic Remission in Ulcerative Colitis

This study is investigating whether a blood protein called LRG (leucine-rich alpha-2-glycoprotein) can serve as a reliable marker to detect when a person with ulcerative colitis has achieved complete healing of the gut lining — known as histologic remission. Currently, confirming remission requires a colonoscopy with biopsy. If LRG can predict this, it may allow doctors to monitor patients less invasively with a simple blood test. **You may be eligible if...** - You are an adult with active ulcerative colitis (an inflammatory bowel disease causing inflammation and ulcers in the large intestine) - You are currently receiving treatment for ulcerative colitis and your doctor is monitoring your response **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study — speak with the research team to confirm your eligibility Talk to your doctor to see if this trial is right for you.